Enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino]benzoic acid, its use in medical therapy, and a pharmaceutical composition comprising it - 026
FJELLSTROM, Ola,GUSTAFSSON, David,JACKSON, Shaun,LUNDBERG, Jan A
申请号：
AU2012268829
公开号：
AU2012268829A1
申请日:
2012.12.21
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
#$%^&*AU2012268829A120130117.pdf#####C:\NRPortbI\DCC\REC\4831309 _.DOC-12/21/2012 ABSTRACT The present invention relates to enantiomerically pure (-) 2-[1-(7-methyl-2-(morpholin-4-yl)- 4 -oxo-4H-pyrido[1,2-a]pyrimidin-9yl)ethylamino]benzoic acid or pharmaceutically acceptable salts thereof, it being in a solid state, its use in medical therapy, pharmaceutical composition comprising it, its use in the preparation of a medicament for use in a method for preventing or treating diseases, and its use in method for preventing or treating disease. The present invention relates to a selective inhibitor of phosphoinositide (PI) 3-kinase B and use of the selective inhibitor in e.g. anti-thrombotic therapy.
